Get the Stockscreener App
33.66
1.37%
0.4387
Roundhill Glp 1 Weight Loss Etf stock is traded at $33.66, with a volume of 26,319.
It is up +1.37% in the last 24 hours and up +22.21% over the past month.
See More
Previous Close:
$33.22
Open:
$33.3504
24h Volume:
26,319
Relative Volume:
2.47
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.52%
1M Performance:
+22.21%
6M Performance:
+39.68%
1Y Performance:
+27.08%
1-Day Range:
$33.32
$33.70
1-Week Range:
$31.96
$33.70
52-Week Range:
$20.01
$33.70
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
Name
Roundhill Glp 1 Weight Loss Etf
Sector
Industry
Phone
-
Address
-
Compare OZEM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OZEM
Roundhill Glp 1 Weight Loss Etf
|
33.65 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
334.67 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
680.24 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
683.60 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
257.47 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
614.63 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Latest News
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Why (OZEM) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Why Is Roundhill Glp-1 & Weight Loss ETF (OZEM) Stock Up Today? - Meyka
Understanding Momentum Shifts in (OZEM) - news.stocktradersdaily.com
5 Sector ETFs Up 10% Despite February's Market Slump - MSN
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - Benzinga
The Investor's Guide to Buying GLP-1 Stocks - The Motley Fool
Avoiding Lag: Real-Time Signals in (OZEM) Movement - news.stocktradersdaily.com
Roundhill GLP-1 & Weight Loss ETF (NQ: OZEM - FinancialContent
Are You Making These 3 ETF Mistakes That Cost You 50% in Gains? - The Motley Fool
N-PX: Others - 富途牛牛
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - sg.finance.yahoo.com
Investing in the Dip: Evaluating ETF Exposure to Eli Lilly Amid Sector Volatility and GLP-1 Growth - AInvest
Will drop go up or down throughout this week - AInvest
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
How to Buy Ozempic Stock - The Motley Fool
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected - The Daily Upside
HRTS: Effectively Thinning Investor Portfolios - ETF.com
The GLP-1 Boom: Why OZEM is Poised to Capitalize on the Obesity Drug Revolution - AInvest
ETFs to Capitalize on the Novo Nordisk-Septerna Deal - TradingView
Roundhill GLP-1 & Weight Loss ETF Review and Aggregate Rating (OZEM) - MarketBeat
Slower flows, small-cap woes, SEC nos! What to expect from ETFs in 2025 - Citywire
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - Zacks Investment Research
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Roundhill GLP-1 & Weight Loss ETF (NASDAQ: OZEM)Dividends - intelligentinvestor.com.au
Tap the Weight-Loss Drug Market With These ETFs - Nasdaq
Ozempic and Weight Loss Drug ETFs Back in Spotlight After Key Earnings Results - Trackinsight
5 ETFs to Make the Most of Eli Lilly's Strength - Zacks Investment Research
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Yahoo Finance
Where to Invest in Health Trends - Bloomberg.com
Roundhill Glp-1 & Weight Loss ETF (OZEM) Holdings - Yahoo! Finance Canada
Novo-Nordisk's "miracle weight-loss drug" has been approved domestically, waiting to explode onto the multi-billion dollar market! How to capture this wave of "weight-loss fever"? - 富途牛牛
Why Investors Haven't Feasted on Two New Weight-Loss ETFs - Investopedia
Weight-loss ETFs demand some heavy thinking - Financial Times
Roundhill Glp-1 & Weight Loss ETF (OZEM) holdings - Yahoo Finance UK
Roundhill Glp-1 & Weight Loss ETF (OZEM) stock price, news, quote and history - Yahoo Finance Singapore
The FSA Spy market buzz – 31 May 2024 - Fund Selector Asia
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk - TradingView
OZEM, Weight Loss Drug ETFs: Should You Invest? - ETF.com
OZEM: ROUNDHILL GLP-1 & WEIGHT LOSS ETFFund Chart - Zacks Investment Research
Roundhill ETF TrustRoundhill GLP-1 & Weight Loss ETF - CMLviz
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF - InvestorPlace
This new weight loss drug ETF bets big on two of the industry's leading players - CNBC
This Week in ETFs: Roster of 17 New ETFs Includes 6 Buffer Funds - ETF Trends
Roundhill GLP-1 & Weight Loss ETF (OZEM) Stock Holdings List - TipRanks
Roundhill GLP-1 & Weight Loss ETF Holdings List (NASDAQ:OZEM) - MarketBeat
Roundhill GLP-1 & Weight Loss ETF (OZEM) Chart and Price History 2025 - MarketBeat
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Financials Data
There is no financial data for Roundhill Glp 1 Weight Loss Etf (OZEM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.86%
Cap:
|
Volume (24h):